Recursion Pharmaceuticals, Inc. (RXRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Recursion Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.84x | -4.00x | -6.25x | -5.65x | -15.64x | -34.30x |
| P/B Ratio | 1.62x | 1.79x | 4.42x | 2.79x | 5.37x | -14.47x |
| P/S Ratio | 24.50x | 31.50x | 46.71x | 34.11x | 291.68x | 874.38x |
| Profitability | ||||||
| Gross Margin | -62.0% | 23.1% | 2.9% | -21.7% | 100.0% | 100.0% |
| Operating Margin | -867.9% | -814.1% | -797.8% | -619.3% | -1827.8% | -2479.2% |
| Net Margin | -863.4% | -788.0% | -747.7% | -603.5% | -1864.8% | -2549.3% |
| EBITDA Margin | -749.0% | -725.2% | -701.1% | -573.7% | -1751.2% | -2393.9% |
| Liquidity | ||||||
| Current Ratio | 5.50x | 3.81x | 4.70x | 5.68x | 11.46x | 11.53x |
| Quick Ratio | 5.50x | 3.81x | 4.70x | 5.68x | 11.46x | 11.53x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.10x | 0.11x | 0.10x | 0.02x | -0.08x |
YoY = year-over-year change. Source: FMP..